| Literature DB >> 35643523 |
Rosa Cabedo-Ferreiro1,2, Maria-Mercedes Vicente-Hernández3,2, Josep-Maria Manresa-Domínguez4,5, Miriam Gómez-Masvidal6,2, Laura Montero-Pons7,8,9, Azahara Reyes-Lacalle10,2, Gemma Falguera-Puig10,2.
Abstract
BACKGROUND: Spanish Organic Law 2/2010 legalizes abortion within 14 weeks of gestation. Medical abortion with mifepristone and misoprostol is around 97% effective and is offered at primary care centers during the first 9 weeks of gestation. It consists of the administration of 200 mg of mifepristone by a healthcare professional and of the self-administration 800 mg of misoprostol by the patient at home, along with prescribed analgesics. However, the quality of this process as perceived by patients has never been assessed. This study aims to validate a scale designed to assess the perceived quality of the entire process, structure and results of at-home medical abortion.Entities:
Keywords: Healthcare quality; Induced abortion; Medical abortion; Satisfaction; Service quality; Validation studies
Mesh:
Substances:
Year: 2022 PMID: 35643523 PMCID: PMC9148507 DOI: 10.1186/s12905-022-01763-5
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.742
Items on the adapted SERVPERF questionnaire to determine the satisfaction of 289 patients who had a medical abortion
| Item | Description | Very poor/poor/normal/good/excellent | ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| P01 | Qualification of the health professionals (abilities, experience, knowledge) | |||||
| P02 | Sense of trust transmitted by the health professionals | |||||
| P03 | Clarity of the information provided | |||||
| P04 | Kindness shown by the health professionals | |||||
| P05 | Interest shown by the health professionals in solving your problems during the process (questions answered, management, monitoring) | |||||
| P06 | Amount of time dedicated to you by the health professionals | |||||
| P07 | Health professionals’ appearance (personal hygiene) | |||||
| P08 | Willingness of the administrative staff to provide immediate service | |||||
| P09 | Training of the administrative staff | |||||
| p10 | Coordination between the fields of healthcare and professional levels (primary care, sexual health, hospital) | |||||
| p11 | Amount of information provided about the process (documents, procedures, possible side effects) | |||||
| p12 | Aesthetics of the healthcare facilities | |||||
| p13 | Ease of the procedures/paperwork | |||||
| p14 | Ease of accessing the service (timetable, access to the center, parking, public transport) | |||||
| p15 | Amount of time until first visit | |||||
| p16 | Amount of time from first visit until the abortion | |||||
| p17 | Information provided to prevent future pregnancies (contraceptive methods) | |||||
| p18 | Information provided about subsequent psychological monitoring and resources | |||||
Fig. 1Participation flow chart. Note: This diagram shows the flow of participants and the reasons for the loss of participants
Sociodemographic characteristics of study participants and dropouts
| Variable | Dropouts (n = 44) | Participants (n = 289) | |
|---|---|---|---|
| Age | 29.07 (10.0) | 29.5 (7.3) | 0.740 |
| Gestational age | 6.25 (1.1) | 6.28 (1.1) | 0.861 |
| 0.316 | |||
| No studies or incomplete | 2 (4.5%) | 11 (3.8%) | |
| Compulsory education | 8 (18.2%) | 91 (31.7%) | |
| High school/vocational school | 26 (59.1%) | 135 (47.0%) | |
| University | 8 (18.2%) | 50 (17.4%) | |
| 0.285 | |||
| Europe (including Spain) | 27 (61.4%) | 201 (70.5%) | |
| Central and South America | 15 (34.1%) | 66 (23.2%) | |
| Morocco and the rest of Africa | 2 (4.5%) | 18 (6.3%) | |
| Paid employment | 22 (66.7%) | 189 (74.4%) | 0.343 |
| 0.662 | |||
| Alone | 6 (14.0%) | 23 (8.1%) | |
| With partner | 113 (30.2%) | 93 (32.7%) | |
| With family | 22 (51.2%) | 154 (54.2%) | |
| In a shared flat | 2 (4.7%) | 14 (4.9%) | |
| Partner | 24 (57.1%) | 187 (68.2%) | 0.165 |
| Family | 24 (57.1%) | 138 (51.3%) | 0.481 |
| Friends | 15 (35.7%) | 70 (26.1%) | 0.195 |
| No social support | 4 (9.5%) | 13 (4.9%) | 0.219 |
| 0.781 | |||
| 0 | 25 (56.8%) | 154 (54.4%) | |
| 1 | 12 (27.3%) | 71 (25.1%) | |
| 2 | 3 (6.8%) | 34 (12.0%) | |
| 3 | 2 (4.5%) | 17 (6.0%) | |
| ≥ 4 | 2 (4.5%) | 7 (2.5%) | |
| 0.998 | |||
| None | 22 (50.0%) | 139 (49.1%) | |
| 1 | 10 (22.7%) | 67 (23.7%) | |
| 2 | 9 (20.5%) | 60 (21.2%) | |
| 3 | 2 (4.5%) | 10 (3.5%) | |
| ≥ 4 | 1 (2.3%) | 7 (2.5%) | |
| Use of contraception | 27 (64.3%) | 162 (58.9%) | 0.508 |
| < 0.001 | |||
| Condom | 14 (51.9%) | 110 (67.9%) | |
| Hormonal | 8 (29.6%) | 52 (32.1%) | |
| IUD | 3 (11.1%) | 0 | |
| Emergency contraception | 2 (7.4%) | 26 (10.2%) | 0.537 |
Description of the responses for each questionnaire item
| Item | (Min.–Max.) | Floor effect | Ceiling effect | Missing records | Mean (SD) |
|---|---|---|---|---|---|
| p1 | (3–5) | 13 (4.5%) | 206 (71.3%) | 4 (1.4%) | 4.7 (0.56) |
| p2 | (2–5) | 3 (1.0%) | 217 (75.1%) | 0 (0.0%) | 4.7 (0.61) |
| p3 | (2–5) | 2 (0.7%) | 216 (74.7%) | 2 (0.7%) | 4.7 (0.55) |
| p4 | (2–5) | 3 (1.0%) | 228 (78.9%) | 2 (0.7%) | 4.7 (0.59) |
| p5 | (2–5) | 2 (0.7%) | 211 (73.0%) | 0 (0.0%) | 4.7 (0.57) |
| p6 | (2–5) | 2 (0.7%) | 176 (60.9%) | 1 (0.3%) | 4.6 (0.62) |
| p7 | (3–5) | 7 (2.4%) | 228 (78.9%) | 6 (2.1%) | 4.8 (0.47) |
| p8 | (1–5) | 1 (0.3%) | 170 (58.8%) | 1 (0.3%) | 4.4 (0.79) |
| p9 | (1–5) | 2 (0.7%) | 156 (54.0%) | 2 (0.7%) | 4.4 (0.79) |
| p10 | (2–5) | 4 (1.4%) | 144 (49.8%) | 2 (0.7%) | 4.4 (0.75) |
| p11 | (2–5) | 3 (1.0%) | 205 (70.9%) | 0 (0.0%) | 4.6 (0.62) |
| p12 | (2–5) | 6 (2.1%) | 117 (40.5%) | 2 (0.7%) | 4.2 (0.80) |
| p13 | (3–5) | 27 (9.3%) | 182 (63.0%) | 1 (0.3%) | 4.5 (0.66) |
| p14 | (1–5) | 2 (0.7%) | 136 (47.1%) | 1 (0.3%) | 4.2 (0.86) |
| p15 | (1–5) | 1 (0.3%) | 148 (51.2%) | 1 (0.3%) | 4.3 (0.81) |
| p16 | (1–5) | 3 (1.0%) | 151 (52.2%) | 2 (0.7%) | 4.3 (0.87) |
| p17 | (1–5) | 1 (0.3%) | 194 (67.1%) | 1 (0.3%) | 4.6 (0.67) |
| p18 | (1–5) | 2 (0.7%) | 149 (51.6%) | 1 (0.3%) | 4.3 (0.85) |
| p19 | (1–5) | 63 (21.8%) | 25 (8.7%) | 3 (1.0%) | 2.6 (1.21) |
| p20 | (1–5) | 34 (11.8%) | 38 (13.1%) | 4 (1.4%) | 3.0 (1.22) |
| p21 | (1–5) | 75 (26.0%) | 7 (2.4%) | 3 (1.0%) | 2.2 (0.98) |
| p22 | (1–5) | 15 (5.2%) | 96 (33.2%) | 5 (1.7%) | 3.6 (1.23) |
| p23 | (1–5) | 20 (6.9%) | 61 (21.1%) | 6 (2.1%) | 3.3 (1.22) |
| p24 | (1–5) | 8 (2.8%) | 219 (75.8%) | 6 (2.1%) | 4.6 (0.92) |
| p25 | (1–5) | 2 (0.7%) | 241 (83.4%) | 2 (0.7%) | 4.8 (0.58) |
| p26 | (1–5) | 5 (1.7%) | 205 (70.9%) | 3 (1.0%) | 4.5 (0.90) |
Min.–Max. Minimum and maximum values obtained for each item; SD Standard deviation
Linearly weighted Kappa coefficient to evaluate intraobserver agreement (test–retest) for each item and overall
| Item | Linearly weighted Kappa coefficient (CI 95%) (N = 53) | |
|---|---|---|
| P01 | 0.715 (0.52–0.91) | 0.000 |
| P02 | 0.709 (0.50–0.92) | 0.000 |
| P03 | 0.810 (0.67–0.95) | 0.000 |
| P04 | 0.744 (0.56–0.93) | 0.000 |
| P05 | 0.691 (0.52–0.86) | 0.000 |
| P06 | 0.480 (0.28–0.68) | 0.000 |
| P07 | 0.627 (0.42–0.83) | 0.000 |
| P08 | 0.413 (0.19–0.64) | 0.000 |
| P09 | 0.756 (0.61–0.90) | 0.000 |
| P10 | 0.657 (0.50–0.81) | 0.000 |
| P11 | 0.460 (0.25–0.67) | 0.000 |
| P12 | 0.655 (0.51–0.80) | 0.000 |
| P13 | 0.567 (0.35–0.78) | 0.000 |
| P14 | 0.572 (0.37–0.78) | 0.000 |
| P15 | 0.549 (0.34–0.76) | 0.000 |
| P16 | 0.662 (0.48–0.85) | 0.000 |
| P17 | 0.398 (0.14–0.65) | 0.000 |
| P18 | 0.555 (0.34–0.77) | 0.000 |
| P19 | 0.612 (0.44–0.79) | 0.000 |
| P20 | 0.514 (0.32–0.71) | 0.000 |
| P21 | 0.644 (0.47–0.82) | 0.000 |
| P22 | 0.594 (0.43–0.76) | 0.000 |
| P23 | 0.674 (0.52–0.82) | 0.000 |
| P24 | 0.639 (0.40–0.87) | 0.000 |
| P25 | 0.612 (0.33–0.89) | 0.000 |
| P26 | 0.576 (0.34–0.82) | 0.000 |
| Overall | 0.681 (0.64–0.72) | 0.020 |
CI 95% Confidence interval 95%
Component matrix with varimax rotation of the 26 items from the adapted SERVPERF questionnaire
| Item | Factorial coefficients of the items after rotation | ||||||
|---|---|---|---|---|---|---|---|
| F1 | F2 | F3 | F4 | F5 | F6 | F7 | |
| p01 | 0.225 | 0.186 | 0.200 | 0.030 | 0.085 | − 0.074 | |
| p02 | 0.102 | 0.131 | 0.122 | 0.080 | − 0.016 | 0.015 | |
| p03 | 0.262 | − 0.106 | 0.418 | 0.096 | − 0.002 | 0.270 | |
| p04 | 0.138 | 0.093 | 0.086 | 0.018 | − 0.017 | 0.114 | |
| p05 | 0.225 | 0.119 | 0.107 | − 0.071 | 0.060 | 0.122 | |
| p06 | 0.155 | 0.448 | 0.292 | − 0.003 | − 0.016 | − 0.001 | |
| p07 | 0.247 | 0.257 | 0.255 | − 0.120 | − 0.015 | 0.092 | |
| p08 | 0.245 | 0.145 | 0.003 | 0.050 | 0.053 | 0.022 | |
| p09 | 0.135 | 0.194 | 0.139 | 0.048 | 0.094 | − 0.008 | |
| p10 | 0.262 | 0.153 | 0.254 | − 0.005 | 0.000 | 0.040 | |
| p11 | 0.302 | 0.283 | 0.036 | 0.172 | − 0.064 | 0.219 | |
| p12 | 0.329 | 0.086 | 0.020 | − 0.002 | − 0.062 | ||
| p13 | 0.363 | 0.296 | 0.181 | 0.077 | − 0.108 | 0.228 | |
| p14 | 0.086 | 0.330 | 0.187 | 0.112 | − 0.014 | 0.187 | |
| p15 | 0.091 | 0.263 | 0.080 | 0.046 | 0.057 | 0.021 | |
| p16 | 0.254 | 0.109 | 0.083 | 0.006 | 0.100 | 0.191 | |
| p17 | 0.397 | 0.109 | 0.361 | − 0.018 | 0.054 | − 0.103 | |
| p18 | 0.263 | 0.202 | 0.255 | 0.077 | 0.146 | − 0.046 | |
| p19 | − 0.037 | 0.074 | − 0.048 | 0.195 | 0.101 | 0.046 | |
| p20 | 0.050 | 0.033 | 0.027 | 0.083 | 0.431 | 0.122 | |
| p21 | 0.010 | − 0.012 | 0.126 | − 0.133 | − 0.030 | − 0.040 | |
| p22 | − 0.010 | 0.042 | 0.076 | 0.152 | 0.010 | − 0.047 | |
| p23 | 0.029 | 0.042 | 0.041 | − 0.022 | 0.305 | − 0.024 | |
| p24 | 0.142 | − 0.092 | − 0.354 | 0.368 | − 0.158 | 0.161 | |
| p25 | 0.248 | 0.098 | 0.129 | 0.014 | − 0.105 | 0.017 | |
| p26 | − 0.018 | − 0.041 | 0.104 | 0.017 | 0.045 | 0.059 | |
| Eigenvalues | 8.088 | 2.379 | 1.743 | 1.482 | 1.332 | 1.104 | 1.008 |
Extraction method: Principal Component Analysis
Rotation method: Varimax normalization. The Kaiser criterion was used with an Eigenvalue > 1 to determine the resulting factors and explained variance (65.9%). In each dimension, those items that presented a saturation value > 0.40. The saturation of elements grouped in each dimension is shown bold and italics with the exception the item P12 in f2 is shown the non-bold italics explained in the Questionnaire dimensions section
Dimensions resulting from the factor analysis, their internal consistency and list of associated items
| Dimensions | Description | Cronbach’s alpha | Number of items | Associated items |
|---|---|---|---|---|
| 1 | Health professionals | 0.861 | 8 | 1, 2, 3, 4, 5, 6, 7, 24 |
| 2 | Administrative staff | 0.824 | 4 | 8, 9, 10, 13 |
| 3 | Organization management | 0.727 | 4 | 12, 14, 15, 16 |
| 4 | Information provided | 0.737 | 3 | 11, 17, 18 |
| 5 | Clinical aspects of the process | 0.676 | 3 | 19, 20, 21 |
| 6 | Impact of the process | 0.749 | 2 | 22, 23 |
| 7 | Satisfaction process | 0.598 | 2 | 25, 26 |
| Overall | 0.862 | 26 | 1–26 |